DB Power and LPA announce strategic partnership to globally expand solutions for issuers of structured retail products

Real Time Search
CES A80 :
CES HKMI :
CES 120 :
Total Turn.

01498 PURAPHARM

Closed Add to Porfolio
Index Constituent : None
Major Shareholders Chan Yu Ling, Abraham & Associates (54.72%) Sector Health Care & Biotechnology
Web Site http://www.purapharm.com Tel (852) 2840-1840
Email info@purapharm.com Fax (852) 2840-0778
Related Equities N/A
Principal Activities Principally engaged in the research and development, production and sale of concentrated Chinese medicine granule (“CCMG”) products and Chinese healthcare products, plantation and trading of raw Chinese herbs, and the manufacture and sale of Traditional Chinese Medicine (“TCM”) decoction pieces as well as the rendering of Chinese medical diagnostic services.

Consolidated List of Substantial Shareholders

Name Number of Shares Interested % of Issued Share Capital (%) Date of Last Notice Filed (Y/M/D)
文綺慧 145,290,720(L)  58.65(L)  16/01/2019
陳宇齡 145,290,720(L)  58.65(L)  16/01/2019
Last Update : 2019-02-28
Note : (L) - Long Position (S) - Short Position (P) - Lending Pool

Complete List of Directors

Director's Name Number of Shares Interested % of issued share capital (%) Date of Last Notice Filed (Y/M/D)
何國華 20,000(L)  0.01(L)  16/06/2018
Last Update : 2019-02-28
Note : (L) - Long Position (S) - Short Position (P) - Lending Pool
Back to Top